Cantel Medical to Ring the Opening Bell at the New York Stock Exchange on January 14, 2010
January 13 2010 - 3:52PM
PR Newswire (US)
LITTLE FALLS, N.J., Jan. 13 /PRNewswire-FirstCall/ -- CANTEL
MEDICAL CORP. (NYSE:CMN) announced today that President and Chief
Executive Officer Andrew Krakauer will ring the Opening Bell at the
New York Stock Exchange at 9:30 a.m. EST January 14, 2010. Krakauer
stated, "It is an honor to celebrate Cantel's continuing success by
participating in the NYSE Opening Bell Ceremony. I look forward to
sharing this privilege and the podium with senior executives from
all of our business units and our corporate office. Our financial
performance over the past two years has been strong and we are
increasing our investment in marketing and product development to
further grow our infection prevention and control company." As a
representation of its dedication to infection prevention and
control, the Company will make a gift to the New York Stock
Exchange of its SaniTyze(TM) brand hand sanitizer. Cantel Medical
Corp. is a leading provider of infection prevention and control
products in the healthcare market. Our products include specialized
medical device reprocessing systems for renal dialysis and
endoscopy, dialysate concentrates and other dialysis supplies,
disposable infection control products primarily for the dental
industry, water purification equipment, sterilants, disinfectants
and cleaners, hollow fiber membrane filtration and separation
products for medical and non-medical applications, and specialty
packaging for infectious and biological specimens. We also provide
technical maintenance for our products and offer compliance
training services for the transport of infectious and biological
specimens. For further information, visit the Cantel website at
http://www.cantelmedical.com/. This press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These statements involve
a number of risks and uncertainties, including, without limitation,
the risks detailed in Cantel's filings and reports with the
Securities and Exchange Commission. Such forward-looking statements
are only predictions, and actual events or results may differ
materially from those projected or anticipated. DATASOURCE: Cantel
Medical Corp. CONTACT: Andrew A. Krakauer, President & CEO,
Cantel Medical Corp., +1-973-890-7220; or Richard E. Moyer, Cameron
Associates, Inc., +1-212-554-5466, Web Site:
http://www.cantelmedical.com/
Copyright